重度α1-抗胰蛋白酶缺乏症增加静脉血栓栓塞风险
本研究基于瑞典国家AATD登记库(n=1577)和OLIN研究对照(n=5969),中位随访18年,发现重度AATD患者VTE发生率为7%,对照组为1%,未调整HR 6.5(95%CI 4.9-8.6),调整后HR 4.2(95%CI 2.9-6.2),提示重度AATD显著增加VTE风险。
要点
- 重度AATD患者VTE风险较一般人群增加约4倍
- 男性、年龄、COPD、癌症和肝病是VTE的危险因素
- 建议对该人群优化危险因素管理和临床随访
核心结论
- 重度AATD个体发生VTE的风险显著高于一般人群,即使调整危险因素后仍然存在。
研究设计与样本
- 基于瑞典国家AATD登记库的重度AATD个体(n=1577)与OLIN研究对照(n=5969)的纵向队列研究,采用多变量Cox回归分析。
主要发现
- 中位随访18年,AATD组116例(7%)发生VTE,对照组89例(1%)发生VTE,未调整HR 6.5(95%CI 4.9-8.6)。
- 调整男性、年龄、COPD、癌症和肝病后,AATD组VTE风险仍显著升高,调整HR 4.2(95%CI 2.9-6.2)。
临床怎么用
- 对重度AATD患者应优化VTE危险因素管理并加强临床随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Severe alpha-1-antitrypsin deficiency (AATD), phenotype PiZZ, is associated with increased risk of liver disease and chronic obstructive pulmonary disease (COPD), but the risk of venous thromboembolism (VTE) is unknown. Our aim was to evaluate the risk of VTE in individuals with severe AATD compared with control subjects from the general population. METHODS: Individuals with severe AATD (n = 1577) were recruited from the Swedish national AATD register. Control subjects (n = 5969) were selected from the OLIN (Obstructive Lung Disease in Northern Sweden) studies, that include a random general population sample. Longitudinal data on VTE and diagnoses were obtained from the Swedish National Patient Registry. Associations were analyzed using multivariable Cox regression. RESULTS: At inclusion, 46% of the AATD individuals and 53% of the controls were never-smokers. COPD was present in 46% of the AATD individuals compared with 4% of the controls. During a median follow-up of 18 years, 116 (7%) of the AATD individuals and 89 (1%) of the control subjects developed VTE, unadjusted hazard ratio 6.5 (95% confidence interval 4.9-8.6). Risk factors for incident VTE were male gender, age, COPD, cancer, and liver disease. Adjusting for these factors, the AATD individuals had a significantly higher risk of incident VTE, adjusted hazard ratio 4.2 (95% confidence interval 2.9-6.2) as compared with the controls. CONCLUSION: Subjects with severe AATD have considerably increased risk of developing VTE compared with the general population, even after accounting for risk factors. This calls for optimized risk factor management and clinical follow-up of this patient group.
引用
- Basil N, Ekström M, Piitulainen E, et al. Severe alpha-1-antitrypsin deficiency increases the risk of venous thromboembolism. J Thromb Haemost. 2021. PMID: 33763945. doi:10.1111/jth.15302
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。